The Good, the Bad, and the Ugly: Australia’s HTA Review Final Report
Brendan Shaw "The HTA Review Report is farsighted enough to be visionary, while being firmly grounded in the practicalities of the here...
top of page
Our Blog
See below for an opinion on current matters around the world.
Search
Brendan Shaw
Oct 267 min read
Is the new price right?: HTA takes a back seat to broader price negotiations
Brendan Shaw I don't always say this but spare a thought for the harried and hapless bureaucrats responsible for managing governments and...
91 views0 comments
Brendan Shaw
Dec 6, 20237 min read
Christmas Santa or Christmas Scrooge?: England's new medicines pricing regime sends mixed messages
Brendan Shaw “I will honour Christmas in my heart and try to keep it all the year. I will live in the Past, the Present, and the Future....
67 views0 comments
Brendan Shaw
Sep 4, 20239 min read
Land of the Long Wait Crowd: problems in New Zealand's medicine funding system
Brendan Shaw "It is so important that New Zealanders are able to access new, emerging and effective cancer treatments that are the...
1,230 views0 comments
Brendan Shaw
Aug 27, 20231 min read
Have health and the PBS come of age as the Intergenerational Report turns 21?
Brendan Shaw Article published in Biopharmadispatch, 28 August 2023, (paywall) which can be found here. #medicines #ageing #economics...
11 views0 comments
Brendan Shaw
May 24, 20221 min read
Pharmaceuticals Take Centre Stage in Australian Election Campaign
Brendan Shaw Article on the 2022 Australian national election campaign published on 25 May in PharmaBoardroom. The article examines the...
20 views0 comments
Brendan Shaw
Dec 8, 20211 min read
Australians now understand there is a 'queue' for new health technologies
Podcast interview of Brendan Shaw with Paul Cross from BioPharmaDispatch, 8 December 2021 that can be heard here. The interview discusses...
32 views0 comments
Brendan Shaw
Sep 11, 20216 min read
NICE methods review, UK Life Sciences Strategy and the life sciences industry: lessons for Australia
Brendan Shaw “We must balance ensuring the NHS gets the best value, delivering improved patient access and promoting innovation. These...
132 views0 comments
Brendan Shaw
Jun 17, 20215 min read
Fair dinkum or collywobbles? Life sciences and the Australia – UK free trade agreement
Brendan Shaw “Fair dinkum – (adj, Australian informal), true, genuine, authentic” - Aussie Slang Dictionary “Collywobbles – (noun, UK...
102 views1 comment
Brendan Shaw
Apr 8, 20211 min read
More risk for government this time around in agreement negotiation
Brendan Shaw Article published in BioPharmaDispatch 9 April 2021 on the risks for government and industry in negotiations on a new...
9 views0 comments
Brendan Shaw
Mar 21, 20215 min read
It's just the vibe: soft skills in the art of government-business relations
Brendan Shaw "It’s just the vibe of the thing.” - Denis Denuto, The Castle “Principle #1: Build strong relationships ahead of time....
102 views0 comments
Brendan Shaw
Jan 14, 20211 min read
5 Trends for Life Science Companies to Watch in 2021
Brendan Shaw Article published in PharmaBoardroom on 14 January 2021 can be found here: https://pharmaboardroom.com/articles/5-trends-for...
15 views0 comments
Brendan Shaw
Oct 14, 20203 min read
The next 20-year PBS agenda: government commitments to new medicines spending
Brendan Shaw If it's real and if it sticks, the Australian government’s ‘New Medicines Funding Guarantee’ will be a significant...
129 views0 comments
Brendan Shaw
Oct 12, 20201 min read
PBS New Medicines Funding Guarantee: echoes of elections past ...
Brendan Shaw Article published in BiopharmaDispatch on 13 October 2020 on the Australian Government's 2020 Budget announcement on funding...
21 views0 comments
bottom of page